Chris Hollowood | BiotechTV

top of page

From London: Syncona CEO Chris Hollowood discusses the firm's public and private funds, and the state of investing in life sciences today from the firm's Capital Markets Day

He talks about Syncona's listed fund, and clarifies the details of a return of capital strategy for some shareholders, and he describes the strategy of the firm's new private fund. Plus, how Syncona thinks about opportunities in life sciences today.

Bright Minds

Mar 19

The CEO of the London-based life science investment firm Syncona shares his thoughts on the sector

Chris Hollowood gives his take on biotech, the UK, portfolio companies iOnctura, Yellowstone Biosciences, and Spur Therapeutics...

Bright Minds

Jun 26, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page

From London: Syncona CEO Chris Hollowood discusses the firm's public and private funds, and the state of investing in life sciences today from the firm's Capital Markets Day

The CEO of the London-based life science investment firm Syncona shares his thoughts on the sector

Follow BiotechTV

Sponsors

Sponsor Spotlight